The last day of trading in warrants of series TO 1 is on the 24th of September 2024

, ,
The 24th of September 2024 is the last day of trading in warrants of series TO 1, which were issued in connection with Diagonal Bio AB's ("Diagonal Bio" or the "Company") preferential rights issue of units that was carried out earlier in 2024.…

The exercise period for warrants of series TO 1 commences today

, ,
Today is the first day for the exercise of Diagonal Bio AB's ("Diagonal Bio" or "the Company") warrants of series TO 1 ("TO 1") which were issued in connection with the preferential issue of units that the Company carried out earlier this year.…

The exercise price for warrants of series TO 1 has been set to SEK 0,05 per new share

, , ,
Diagonal Bio AB ("Diagonal Bio" or "the Company") hereby announces that the exercise price for the warrants of series TO 1 (”TO 1”), which were issued in connection with the rights issue of units that the Company executed earlier…

Diagonal Bio announces successful external validation of LAMPlify® for respiratory viruses in horses

, , , ,
Diagonal Bio AB (publ) (“Diagonal Bio” and “the Company”) announces that its diagnostic tool, LAMPlify® has undergone a successful external validation in accordance with ISO 17025 standards. It is confirming that…

Diagonal Bio AB Second Quarter Report (Q2 2024)

, , , , , , ,
“In the second quarter of 2024, we have made advancements, particularly within the equine healthcare sector (horse veterinary clinics) where our connections and the interest in our Point-of-Care instrument continue to deepen.”Summary…

Diagonal Bio receives order from the Technical University of Denmark

, , , ,
Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) has secured an order from the Technical University of Denmark (“DTU”) valued at just over 210,000 SEK for fish farms’ health project HURTIGFISK.…

Bulletin from the Annual General Meeting on 11 June 2024 in Diagonal Bio AB

, , ,
Today, on 11 June 2024, the Annual General Meeting of Diagonal Bio AB was held. A summary of the adopted resolutions follows below.Resolution on adoption of the accounts and appropriation of profitThe Annual General Meeting resolved to adopt…

Kommuniké från årsstämma den 11 juni 2024 i Diagonal Bio AB

, , ,
Idag, den 11 juni 2024, hölls årsstämma i Diagonal Bio AB. Nedan följer en sammanfattning av de beslut som fattades. Beslut om fastställande av räkenskaper samt resultatdispositionÅrsstämman beslutade…

Diagonal Bio AB first quarter (Q1 2024)

, , , , , ,
“The end of last year was marked by our focus on creating the business platform to generate the company's initial revenue in 2024. We continue and gear up on the set path with a focus on generating revenue”.Summary of Q1 report 20242024-01-01…

Diagonal Bio appoints new CFO

, , ,
Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) has appointed Fata Mrsic as the new Chief Financial Officer (CFO). Fata will assume the position on June 14, 2024, and be part of the Management Team.Fata Mrsic…